Bioton boosts profit predictions after jumps in market share and exports

The strong performance led the company to increase its net profit prognosis for this year by zł.7 million to zł.35 million. The president of the company Adam Wilczęga believes that Bioton will also boost its market share, and estimates it will possess 25% of the insulin market by the end of the year. He justifies his plans by unexpected gains of Bioton on this market so far, as the company boosted its share from 7% in December 2004 to 16% at present. Bioton is expanding also on foreign markets in Central America, the Caribbean as well as Belorussia, Ukraine and Bulgaria. (Puls Biznesu p. 11) M.G.